Financial toxicity risk among adult patients undergoing cancer surgery in the United States: An analysis of the National Inpatient Sample
- 24 June 2019
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (3) , 397-406
Abstract
Background and Objective: Financial hardship occurring as a result of cancer treatment has been termed financial toxicity and is an established side effect of the cancer treatment. We investigated the risk of financial toxicity among patients undergoing surgery for gastrointestinal cancers.Methods: All uninsured and privately insured patients who underwent surgery for a gastrointestinal cancer were identified from the National Inpatient Sample. Publicly available government data were used estimate income, food expenditure, and average maximum out‐of‐pocket expenditure. Risk of financial toxicity was defined as health expenditure ≥ 40% of postsubsistence income.Results: Among the 78 545 patients in the analytic cohort, 73 305 individuals had private insurance while 5240 patients were uninsured. Overall median hospital charges were $58 651 (IQR: $37 912‐$95 379). Approximately 90% of uninsured and 10% of privately insured patients were at risk of financial toxicity. At the subpopulation level, patients in the lowest income quartile, undergoing emergency surgery, black or hispanic individuals, and those undergoing surgery for esophageal or colon cancer were more likely to experience catastrophic costs following surgery (P < .001).Conclusion: Approximately 9 in 10 uninsured and 1 in 10 privately insured patients with cancer were at risk of financial toxicity after the surgery. Targeted interventions are needed to provide financial protection to patients undergoing the cancer treatment.Keywords
This publication has 17 references indexed in Scilit:
- Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategiesJournal of Surgical Oncology, 2019
- Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer CareJAMA Oncology, 2017
- Financial Insolvency as a Risk Factor for Early Mortality Among Patients With CancerJournal of Clinical Oncology, 2016
- Global cancer surgery: delivering safe, affordable, and timely cancer surgeryThe Lancet Oncology, 2015
- Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic developmentThe Lancet, 2015
- Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer PatientsThe Oncologist, 2015
- Catastrophic expenditure to pay for surgery worldwide: a modelling studyThe Lancet Global Health, 2015
- Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer DiagnosisHealth Affairs, 2013
- The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's ExperienceThe Oncologist, 2013
- A Convenient Descriptive Model of Income Distribution: The Gamma DensityEconometrica, 1974